- $62.56bn
- $95.82bn
- $15.33bn
- 75
- 55
- 89
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 13,209 | 11,700 | 16,610 | 19,200 | 15,334 |
Cost of Revenue | |||||
Gross Profit | 7,360 | 6,680 | 7,749 | 7,290 | 7,589 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8,336 | 10,140 | 13,694 | 15,135 | 11,138 |
Operating Profit | 4,873 | 1,560 | 2,916 | 4,065 | 4,196 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,165 | 661 | 2,219 | 3,335 | 3,201 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,239 | 180 | 1,850 | 2,625 | 2,486 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2,190 | 119 | 1,784 | 2,548 | 2,391 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,178 | 106 | 1,770 | 2,535 | 2,377 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.668 | 0.602 | 1.3 | 1.12 | 1.07 |
Dividends per Share |